<code id='4958BB27C6'></code><style id='4958BB27C6'></style>

<acronym id='4958BB27C6'></acronym>

<center id='4958BB27C6'><center id='4958BB27C6'><tfoot id='4958BB27C6'></tfoot></center><abbr id='4958BB27C6'><dir id='4958BB27C6'><tfoot id='4958BB27C6'></tfoot><noframes id='4958BB27C6'>

<optgroup id='4958BB27C6'><strike id='4958BB27C6'><sup id='4958BB27C6'></sup></strike><code id='4958BB27C6'></code></optgroup>

<b id='4958BB27C6'><label id='4958BB27C6'><select id='4958BB27C6'><dt id='4958BB27C6'><span id='4958BB27C6'></span></dt></select></label></b><u id='4958BB27C6'></u>

~~<i id='4958BB27C6'><strike id='4958BB27C6'><tt id='4958BB27C6'><pre id='4958BB27C6'></pre></tt></strike></i>~~

Home» focus» knowledge

knowledge

knowledge

author：fashion 2025-10-04 10:25:05 Page View：84532

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

advertisement

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Do more moles mean more problems? Not so, says new study
Next article： Medicare details structure of new drug price negotiation program

leisure time

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

WASHINGTON--TheSupremeCourtwillreviewarulingstrikingdownadomesticviolencefederalgunban.

Kenai launches with $82 million for Parkinson’s stem cell therapy

Kenai launches with $82 million for Parkinson’s stem cell therapy

AdobeThedreamofbeingabletopluckacelltherapyoffofafreezershelfandspeedilygiveittocancerpatientsismate

Duchenne breakthrough therapy leaves behind pioneering families

Duchenne breakthrough therapy leaves behind pioneering families

DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

David Sabatini, ex

DavidSabatiniposedathishomeinCambridgein2022.CraigF.Walker/BostonGlobeFormerMITandWhiteheadInstitute

read more